Session » 3S041 ACR/ARHP: Patient Perspectives Poster Session

Date: Sunday, October 21, 2018

Time: 12:00PM-2:00PM

Meeting: 2018 ACR/ARHP Annual Meeting

12:00PM-2:00PM: Abstract Number: PP08

Communication, Support, and Advocacy Lead to Improved Health and Quality of Life

12:00PM-2:00PM: Abstract Number: PP09

Improved Quality of Life and Decreased Symptoms of Lupus with Diet, Exercise, and Functional Medicine

12:00PM-2:00PM: Abstract Number: PP04

Improved Quality of Life with Patient Engagement in Research

12:00PM-2:00PM: Abstract Number: PP05

Integrative Approach to Treatment of an Adult with Juvenile Rheumatoid Arthritis

12:00PM-2:00PM: Abstract Number: PP06

Learning to Self-Advocate in the Transition from Pediatric to Adult Lupus Care

12:00PM-2:00PM: Abstract Number: PP12

Living a Full Life with A.S. Through Adaptations

12:00PM-2:00PM: Abstract Number: PP03

Managing OsteoArthritis Pain with Daily Meditation

12:00PM-2:00PM: Abstract Number: PP01

Physician, Patient, Person. Success in Balancing Multiple Roles Takes Support

12:00PM-2:00PM: Abstract Number: PP07

Strengthening My Resiliency: How My Interprofessional Healthcare Team and I Improved My Management of Lupus

12:00PM-2:00PM: Abstract Number: PP13

Support Groups and Patient Centred Care; Making a Difference in the Lives of People with Autoimmune and Rheumatic Conditions in Ghana

12:00PM-2:00PM: Abstract Number: PP02

Sustained Weight Loss Managed by Multiple Medical Specialists

12:00PM-2:00PM: Abstract Number: PP11

The Road Less Traveled– Nontraditional Approaches to Increased Patient Adherence and Positive Outcomes

12:00PM-2:00PM: Abstract Number: PP10

Using a Mobile App to Facilitate Patient-Doctor Discussions to Make Informed Decisions Regarding ‘Painsomnia’

« View all sessions from this meeting

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].